» Articles » PMID: 21546419

Arsenic Exposure from Drinking Water and Mortality from Cardiovascular Disease in Bangladesh: Prospective Cohort Study

Overview
Journal BMJ
Specialty General Medicine
Date 2011 May 7
PMID 21546419
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the association between arsenic exposure and mortality from cardiovascular disease and to assess whether cigarette smoking influences the association.

Design: Prospective cohort study with arsenic exposure measured in drinking water from wells and urine.

Setting: General population in Araihazar, Bangladesh.

Participants: 11,746 men and women who provided urine samples in 2000 and were followed up for an average of 6.6 years.

Main Outcome Measure: Death from cardiovascular disease.

Results: 198 people died from diseases of circulatory system, accounting for 43% of total mortality in the population. The mortality rate for cardiovascular disease was 214.3 per 100,000 person years in people drinking water containing <12.0 µg/L arsenic, compared with 271.1 per 100,000 person years in people drinking water with ≥ 12.0 µg/L arsenic. There was a dose-response relation between exposure to arsenic in well water assessed at baseline and mortality from ischaemic heart disease and other heart disease; the hazard ratios in increasing quarters of arsenic concentration in well water (0.1-12.0, 12.1-62.0, 62.1-148.0, and 148.1-864.0 µg/L) were 1.00 (reference), 1.22 (0.65 to 2.32), 1.35 (0.71 to 2.57), and 1.92 (1.07 to 3.43) (P = 0.0019 for trend), respectively, after adjustment for potential confounders including age, sex, smoking status, educational attainment, body mass index (BMI), and changes in urinary arsenic concentration since baseline. Similar associations were observed when baseline total urinary arsenic was used as the exposure variable and for mortality from ischaemic heart disease specifically. The data indicate a significant synergistic interaction between arsenic exposure and cigarette smoking in mortality from ischaemic heart disease and other heart disease. In particular, the hazard ratio for the joint effect of a moderate level of arsenic exposure (middle third of well arsenic concentration 25.3-114.0 µg/L, mean 63.5 µg/L) and cigarette smoking on mortality from heart disease was greater than the sum of the hazard ratios associated with their individual effect (relative excess risk for interaction 1.56, 0.05 to 3.14; P = 0.010).

Conclusions: Exposure to arsenic in drinking water is adversely associated with mortality from heart disease, especially among smokers.

Citing Articles

Biomonitoring and Health Risk Assessment of Arsenic Contamination in Drinking Water among Rural Residents in Western Tehran.

Harati M, Tabatabaei Jabali S, Abdossalami Asl Y, Chinichian M, Donyavi T, Bahari N PLoS One. 2025; 20(2):e0317527.

PMID: 39946449 PMC: 11824981. DOI: 10.1371/journal.pone.0317527.


An Assessment of Multipollutant Exposures Using Silicone Wristbands Among Bangladeshi Youth.

Quaid M, Haque S, Islam T, Shahriar M, Sarwar G, Ahmed A Int J Environ Res Public Health. 2025; 21(12).

PMID: 39767529 PMC: 11675965. DOI: 10.3390/ijerph21121691.


Long-Term Exposure to Arsenic in Community Water Supplies and Risk of Cardiovascular Disease among Women in the California Teachers Study.

Medgyesi D, Bangia K, Spielfogel E, Fisher J, Madrigal J, Jones R Environ Health Perspect. 2024; 132(10):107006.

PMID: 39440943 PMC: 11498017. DOI: 10.1289/EHP14410.


Epidemiology, Mechanisms and Prevention in the Etiology of Environmental Factor-Induced Cardiovascular Diseases.

Ahmed Z, Chaudhary F, Agrawal D J Environ Sci Public Health. 2024; 8(2):59-69.

PMID: 38911615 PMC: 11192553. DOI: 10.26502/jesph.96120206.


Arsenic Exposure-Related Hypertension in Bangladesh and Reduced Circulating Nitric Oxide Bioavailability.

Khatun M, Haque N, Siddique A, Wahed A, Islam M, Khan S Environ Health Perspect. 2024; 132(4):47003.

PMID: 38573329 PMC: 10993991. DOI: 10.1289/EHP13018.


References
1.
Meliker J, Wahl R, Cameron L, Nriagu J . Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health. 2007; 6:4. PMC: 1797014. DOI: 10.1186/1476-069X-6-4. View

2.
Simeonova P, Luster M . Arsenic and atherosclerosis. Toxicol Appl Pharmacol. 2004; 198(3):444-9. DOI: 10.1016/j.taap.2003.10.018. View

3.
Greenland S, Robins J . Invited commentary: ecologic studies--biases, misconceptions, and counterexamples. Am J Epidemiol. 1994; 139(8):747-60. DOI: 10.1093/oxfordjournals.aje.a117069. View

4.
Srivastava S, Vladykovskaya E, Haberzettl P, Sithu S, DSouza S, States J . Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol Appl Pharmacol. 2009; 241(1):90-100. PMC: 4414341. DOI: 10.1016/j.taap.2009.08.004. View

5.
Tseng C, Chong C, Chen C, Tai T . Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology. 1997; 48(4):321-35. DOI: 10.1177/000331979704800405. View